Research

New study Equazen® mumomega®

Research

New study Equazen® mumomega®

SFI Health is happy to announce the first investigation that shows measurable anatomical changes (MRI scans) in the brain of infants in response to maternal supplementation with fatty acids using Equazen® mumomega®. The clinical trial was conducted at the Chelsea & Westminster Hospital London, UK and published in the scientific journal Prostaglandins Leukotrienes Essential Fatty Acids (PLEFA 138 (2018) 6-13). This is the first study to show maternal BSFA supplementation enhances newborn infant’s brain size and suggests differential sex sensitivity of fetal brains to pregnancy BSFA status.

Learn

Research is important, and we want to share it. Our articles distill the complex research and offer expert analysis on the microbiome, brain health and wellbeing.
Microbiome

Could modifying your gut microbiome help manage IBS symptoms?

If you’re one of the millions living with the often-debilitating pain and sometimes embarrassing symptoms of Irritable Bowel Syndrome (IBS), you probably know how challenging this condition can be. You’ll...

Read more
Cognitive Health

Cognitive health over a lifetime – how it changes and...

Cognitive health describes the ability to learn, think and remember. Not surprisingly, cognitive health is a key component of healthy ageing as it is vital in maintaining a good quality...

Read more
Wellbeing

Navigating the early stages of menopause – naturally

Early menopause is a time of changes in a woman's body. Although these natural changes may make you feel uncomfortable, there are things you can do to still feel good....

Read more